Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$112.05 USD
+5.73 (5.39%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $112.09 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Brokerage Reports
Jazz Pharmaceuticals PLC [JAZZ]
Reports for Purchase
Showing records 1 - 20 ( 249 total )
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Despite Muddled 1Q, 2024 Guidance Reiterated; Stock Unjustifiably at All-Time Low Multiples; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Stock Reflects Overly Pessimistic Prognosis and Little, If Any, Pipeline Value; Adding Zani For BTC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Genomic Medicine Deep Dive-Redrawing Frontiers at the Coding Level
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Optimized Entry and Exit Levels for JAZZ 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department